Nourianz Will Be a New Add-On for Parkinson's

February 2020

Nourianz (NUR-ee-anz, istradefylline) will be a new add-on med for Parkinson's disease.

It's for "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms (tremor, rigidity, etc) return.

But Nourianz doesn't seem to reduce "off" time more than other add-ons...such as entacapone, pramipexole, or rasagiline.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Prevent Common Issues With Med Delivery
Infectious Diseases Think of Recarbrio as Similar to Avycaz and Vabomere
Heart Failure Keep Meds for "LVAD" Patients Straight
CPR Avoid Mishaps if Your Pharmacy Stocks Bretylium
Seizures Anticipate Treating Seizures Fast With IV Levetiracetam
Parkinson's Disease Nourianz Will Be a New Add-On for Parkinson's
Med Administration Gather Info to Guide Redosing of a Med After Vomiting
Cystic Fibrosis Expect Trikafta for Cystic Fibrosis to Be Continued In-House
Emergency Medicine Expedite Treatment for Stimulant Overdoses